Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Temozolomide Metabolite-MTIC D3

Stable Isotopes
CAT No.
:
CS-O-12030

CAS No.

:

1232679-46-7 (Unlabeled)

Molecular Weight

:

171.18

Molecular Formula

:

C5H5D3N6O

Purity

:

>98%

HS Code:

:

28459090

 


Useful information

"Temozolomide (TMZ; brand names Temodar and Temodal and Temcad) is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.",""



Product Application Notes

Labeled Temozolomide metabolite, intended for use as an internal standard for the quantification of Temozolomide metabolite by GC- or LC-mass spectrometry.



Synonyms

5‐[(1E)‐3‐(D3)methyltriaz‐1‐en‐1‐yl]‐1H‐imidazole‐4‐ carboxamide



References

Newlands, E.S., et al.:cacer Treat. Rev., 23, 35 (1997), Kim,c., et al.: J. Biol.chem., 274, 1233



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Temozolomide Metabolite-MTIC D3 Cas # 1232679-46-7 (Unlabeled) and its Stable Isotopes.

Temozolomide Metabolite-MTIC D3 Temozolomide Metabolite-MTIC D3 Worldwide Suppliers of Temozolomide Metabolite-MTIC D3 Stable Isotopes Clearsynth 1232679-46-7 (Unlabeled)

Product rating: 9 Temozolomide Metabolite-MTIC D3 based on 20 ratings

  1. Stable Isotopes

  2. Temozolomide Metabolite-MTIC D3



Keywords

Keywords: Temozolomide Metabolite-MTIC D3, CS-O-12030, 1232679-46-7 (Unlabeled), 5‐[(1E)‐3‐(D3)methyltriaz‐1‐en‐1‐yl]‐1H‐imidazole‐4‐ carboxamide, C5H5D3N6O, 171.18, Labeled Temozolomide metabolite, intended for use as an internal standard for the quantification of Temozolomide metabolite by GC- or LC-mass spectrometry.
Internal standard, Internal standard Temozolomide, HPLC-MS method validation, HPLC-MS method validation Temozolomide, LC-MS-MS method validation, LC-MS-MS method validation Temozolomide, Deuterated internal standard, Deuterated internal standard Temozolomide, Deuterated Temozolomide, Deuterium labeled Temozolomide, Quantitative bioanalytical methods, Quantitative bioanalytical methods Temozolomide, Blood samples Temozolomide, Blood concentrations, Heavy drugs, Analysis, Analysis Temozolomide, Clinical diagnostic, Clinical diagnostic Temozolomide, Dosing Temozolomide, Analytical method development, Internal standard method.



Related result for 'Temozolomide Metabolite-MTIC D3'

- Temozolomide : API Standards

- Temozolomide : Stable Isotopes

- Temozolomide : Metabolites

- Temozolomide : Impurities

- Temozolomide : Intermediates



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945